Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Protagonist Therapeutics, Inc | tm2013080d1_8k.htm |
Exhibit 16.1
March 18, 2020
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Protagonist Therapeutics, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K of Protagonist Therapeutics, Inc. dated March 13, 2020. We agree with the statements concerning our Firm contained therein.
| Very truly yours, | |
| /s/ PricewaterhouseCoopers LLP | |
| San Jose, California | |
| Attachment |
PricewaterhouseCoopers LLP, 488 Almaden Boulevard, suite 1800, San Jose, CA 95110
T: (408) 817 3700, F: (408) 817 5050, www.pwc.com/us